{"id":"tp-49942","type":"article-newspaper","title":"PROCEPT BioRobotics Targets Positive Adjusted EBITDA in Q4 2026","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/49942","datePublished":"2026-11-06T07:43:44.000Z","dateModified":"2026-11-06T07:43:44.000Z","language":"en","abstract":"The company projects 2026 revenue of $390 million to $410 million and a full-year adjusted EBITDA loss of $30 million to $35 million.","section":"Business","references":[]}